Leber Congenital Amaurosis (LCA) Market Share and Size,
Trends and Growth, Market Insights, Outlook and Pipeline
Review, H1 2016
Global Markets Direct's, 'Leber Congenital Amaurosis (LCA) - Pipeline Review, H1 2016', provides an
overview of the Leber Congenital Amaurosis (LCA) pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Leber
Congenital Amaurosis (LCA), complete with analysis by stage of development, drug target, mechanism of
action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive
pharmacological action of the therapeutics, its complete research and development history and latest
news and press releases. Additionally, the report provides an overview of key players involved in
therapeutic development for Leber Congenital Amaurosis (LCA) and features dormant and discontinued
projects.
Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications. The report is built using data and information sourced from Global
Markets Direct's proprietary databases, company/university websites, clinical trial registries,
conferences, SEC filings, investor presentations and featured press releases from company/university
sites and industry-specific third party sources.
Browse Detail Report With TOC @ https://www.radiantinsights.com/research/leber-congenitalamaurosis-lca-pipeline-review-h1-2016
Scope
The report provides a snapshot of the global therapeutic landscape of Leber Congenital Amaurosis (LCA)
The report reviews pipeline therapeutics for Leber Congenital Amaurosis (LCA) by companies and
universities/research institutes based on information derived from company and industry-specific
sources
Table Of Content
Table of Content 2
List of Tables 4
Browse Upcoming Reports @ http://www.radiantinsights.com/upcoming-reports
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Leber Congenital Amaurosis (LCA) Overview 6
Therapeutics Development 7
Pipeline Products for Leber Congenital Amaurosis (LCA) - Overview 7
Pipeline Products for Leber Congenital Amaurosis (LCA) - Comparative Analysis 8
Leber Congenital Amaurosis (LCA) - Therapeutics under Development by Companies 9
Leber Congenital Amaurosis (LCA) - Therapeutics under Investigation by Universities/Institutes 10
Leber Congenital Amaurosis (LCA) - Pipeline Products Glance 11
Late Stage Products 11
Clinical Stage Products 12
Early Stage Products 13
Leber Congenital Amaurosis (LCA) - Products under Development by Companies 14
Browse Full Report @ https://www.radiantinsights.com/research/leber-congenital-amaurosis-lcapipeline-review-h1-2016
About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business
intelligence requirements. We assist and facilitate organizations and individuals procure market research
reports, helping them in the decision making process. We have a comprehensive collection of reports,
covering over 40 key industries and a host of micro markets. In addition to over extensive database of
reports, our experienced research coordinators also offer a host of ancillary services such as, research
partnerships/ tie-ups and customized research solutions.
Contact Details:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
28 2nd Street,
Suite 3036 San Francisco,
CA 94105 United States
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Website: http://www.radiantinsights.com/
Email: [email protected]